Stock listing
A3DL82 Stock Price, News, Filings & Events — Abl Diagnostics Sa
Selected listing: A3DL82 · LS · EUR · DE
This page tracks Abl Diagnostics Sa's A3DL82:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3DL82:LS. A3DL82:LS is the stock-level entry point for investors researching Abl Diagnostics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
- Ticker
- A3DL82:LS
- Asset type
- Stock
- Market cap
- $44.9M
- Sector
- Finance
- Industry
- Financial Conglomerates
- Exchange
- LS
- Currency
- EUR
Abl Diagnostics Sa A3DL82:LS stock context
This page tracks Abl Diagnostics Sa's A3DL82:LS listing on LS in EUR for DE, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following A3DL82:LS. A3DL82:LS is the stock-level entry point for investors researching Abl Diagnostics Sa, while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary.
Latest news from Abl Diagnostics Sa
ABL Diagnostics Announces Availability of the Latest All Invest Securities Research Report
September 14, 2026
ABL Diagnostics (ABLD) Announces the Filing of a Takeover Bid for Integragen
September 11, 2026
ABL Diagnostics - TEXCELL Strengthens Its Position as an International Reference in Safety and Viral Clearance With a New Strategic Partn...
September 10, 2026
ABL Diagnostics Confirms Its Change of Scale in the First Half of 2026: Revenue up 90.0%, EBITDA Multiplied by More Than Four and Net Inc...
September 8, 2026
ABL Diagnostics: Ordinary and Extraordinary General Meeting of September 17, 2026 – Arrangements for the Availability and Consultation of...
August 27, 2026
Research Abl Diagnostics Sa
Abl Diagnostics Sa investor report
Review AI stock analysis and investor report context for A3DL82:LS.
Abl Diagnostics Sa company profile
View the public company page for Abl Diagnostics Sa on 6ix.
Abl Diagnostics Sa news
Read company news and market updates connected to Abl Diagnostics Sa.
Abl Diagnostics Sa investor events
Find investor webinars, events, and replay context for Abl Diagnostics Sa.
Alternate listings
ABLD:EURONEXT
FR · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is A3DL82:LS.
A3DL82:LSX
DE · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is A3DL82:LS.
ABLDP:AQUISUK
GB · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is A3DL82:LS.
ABLDP:AQUISEU
GB · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is A3DL82:LS.
9BK0:FWB
DE · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is A3DL82:LS.
9BK0:SWB
DE · EUR
Alternate listing for Abl Diagnostics Sa; the primary context on this page is A3DL82:LS.